BARBIERI, ENZA
BARBIERI, ENZA
DIP. CLINICO SCIENZE RADIOLOGICHE E ISTOCITOPATOLOGICHE
Barbieri E; Enza Barbieri; BARBIERI; E.BARBIERI
Cytoplasmatic compartmentalization by Bcr-Abl promotes TET2 loss-of-function in chronic myeloid leukemia
2012 Manuela Mancini;Nevena Veljkovic;Elisa Leo;Michela Aluigi;Enrica Borsi;Chiara Galloni;Ilaria Iacobucci;Enza Barbieri;Maria Alessandra Santucci
Gadd45a transcriptional induction elicited by the Aurora kinase inhibitor MK-0457 in Bcr-Abl-expressing cells is driven by Oct-1 transcription factor
2012 Manuela Mancini;Elisa Leo;Michela Aluigi;Chiara Marcozzi;Enrica Borsi;Enza Barbieri;Maria Alessandra Santucci
Histone H3 covalent modifications driving response of BCR-ABL1+ cells sensitive and resistant to imatinib to Aurora kinase inhibitor MK-0457
2012 Mancini M.; Aluigi M.; Leo E.; Marcozzi C.; Castagnetti F.; Barbieri E.; Santucci MA.
IG-IMRT VS HDR-BRT in low risk prostate cancer: comparison of techniques. The Sant'Orsola-Malpighi's Hospital experience
2012 Bordonaro L.; Pieri M.; Capuccini J.; Cammelli S.; Galuppi A.; Veraldi a.; Tolento G.; Ntreta M.; Angelini a.; Romani F.; Bertaccini A.; Barbieri E.; Mazzarotto R.
Soft tissue sarcoma treated with postoperative pulsed-dose-rate brachytherapy and external beam radiotherapy
2012 Medoro S.; Galuppi A.; Cammelli S.; Bordonaro L.; Arcelli A.; Ferraro A.; Lombardo E.; BIanchi G.; Barbieri E.
The role of brachytherapy in the treatment of vulvar cancer
2012 Cima S.; Arcelli A.; Galuppi A.; S. Cammelli; Enzo L.; Barbieri E.
Chemotherapy followed by chemoradiotherapy in locally advanced pancreatic cancer:A literature review and report of two cases
2011 Di Marco M; Macchini M; Vecchiarelli S; Casadei R; Pezzilli R; Fanti S; Zanoni L; Calculli L; Barbieri E; Santini D; DI Cicilia R; Brandi G; Biasco G.
Hupofractionated IG-IMRT and acute toxicity in prostate cancer: the experience of the department of radiotherapy Sant'Orsola-Malpighi Hospital, Bologna
2011 M.Mazza; A.Malorgio; F.Bunkheila; S.Cammelli; M.Ntreta; A.Angelini; A.Bertaccini; R.Mazzarotto; E.Barbieri
Nonmetastatic Ewing family tumors: high-dose chemotherapy with stem cell rescue in poor responder patients. Results of the Italian Sarcoma Grouo/Scandinavian Sarcoma Group III protocol
2011 S. Ferrari; H.K. Sundby; R. Luksch; A. Tienghi; T. QWiebe.F. Fagioli; TA Alvegard; A. Brach Del Prever; A. Tamburini; M. Alberghini. L. Gendola; M. Mercuri; R. Capanna; S. Mapelli; A. Prete; M. Carli; P. Picci; E. Barbieri; G. Bacci; S. Smeland
Randomised clinical trial: preventive treatment with topical rectal beclomethasone dipropionate reduces post-radiation risk of bleeding in patients irradiated for prostate cancer
2011 Fuccio L; Guido A; Laterza L; Eusebi LH; Busutti L; Bunkheila F; Barbieri E; Bazzoli F.
Successful radiotherapy for local control of progressively increasing metastasis of gastrointestinal stromal tumor.
2011 Lolli C.; Pantaleo M.A.; Nannini M.; Saponara M.; Pallotti M.C.; Di Scioscio V.; Barbieri E.; Mandrioli A.; Biasco G.
A new non peptidic inhibitor of the 14-3-3 docking site induces apoptotic cell death in cronic myloid leukemia sensitive or resistant to imatinib.
2010 M. Mancini. V. Corradi; S. Petta; E. Barbieri; F. Manetti; M: Notta; MA Santucci
Image-guided radiotherapy in real time with 3D-conformational radiotherapy with epid system imagin in prostate cancer.
2010 S.CAMMELLI; C.BLASI; L.BORDONARO; F.BUNKHEILA; F.LABROPOULOS; A.MALORGIO; M.MAZZA; M.PIERI; E.BARBIERI; R.MAZZAROTTO
Lithium induces mortality in medulloblastoma cell lines
2010 Ronchi A; Salaroli R; Rivetti S; Della Bella E; Di Tomaso T; Voltattorni M; Cammelli S; Ceccarelli C; Giangaspero F; Barbieri E; Cenacchi G.
mTOR inhibitor RAD001 (Everloimus) enhances the effects of imatinib in chronic myeloid leukemia by raising the nuclear expression of c-Abl protein
2010 M. Mancini; V. Corradi; S. Petta; G. Martinelli; E. Barbieri; M.A. Santucci
Neoadjuvant therapy for resectable pancreatic adenocarcinoma: An interim report of a prospective randomized study
2010 M. Di Marco; M. Macchini; R. di Cicilia; S. Vecchiarelli; R. Casadei; E. Barbieri; L. Calculli; M. A. Pantaleo; G. Biasco
Prognostic factors in resected pancreatic cancer:a single centre experience
2010 M.Di Marco;M.Macchini|;M.D'ambra;C.Ricci|;S.Vecchiarelli;M.C.Pallotti;;B.Melotti;F.Sperandi;R.Pezzilli;L.Calculli;D.Santini;E.Barbieri;C.Serra;R. Casadei;F.Minni;A.A.Martoni;G.Biasco
RAD001 (everolimus) prevents mTOR and Akt late re-activation in response to imatinib in chronic myeloid leukemia
2010 M. Mancini; S. Petta; G. Martinelli; E. Barbieri; M.A. Santucci
Radiotherapy treatment for pediatric central nervous system tumours (CNS)
2010 A.CECCONI; A.GUIDO; L.TONTINI; F.BUNKHEILA; A.PRETE; E.BARBIERI
Risk Factors in Resected Pancreatic Cancer. A Single Centre Experience
2010 Macchini M1; Vecchiarelli S; Di Marco M; D’Ambra M; Ricci C; Pallotti MC; Melotti B; Sperandi F; Pezzilli R; Calculli L; Santini D; Barbieri E; Serra C; Casadei R; Minni F; Martoni AA; Biasco G
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Cytoplasmatic compartmentalization by Bcr-Abl promotes TET2 loss-of-function in chronic myeloid leukemia | Manuela Mancini;Nevena Veljkovic;Elisa Leo;Michela Aluigi;Enrica Borsi;Chiara Galloni;Ilaria Iaco...bucci;Enza Barbieri;Maria Alessandra Santucci | 2012-01-01 | JOURNAL OF CELLULAR BIOCHEMISTRY | - | 1.01 Articolo in rivista | - |
| Gadd45a transcriptional induction elicited by the Aurora kinase inhibitor MK-0457 in Bcr-Abl-expressing cells is driven by Oct-1 transcription factor | Manuela Mancini;Elisa Leo;Michela Aluigi;Chiara Marcozzi;Enrica Borsi;Enza Barbieri;Maria Alessan...dra Santucci | 2012-01-01 | LEUKEMIA RESEARCH | - | 1.01 Articolo in rivista | - |
| Histone H3 covalent modifications driving response of BCR-ABL1+ cells sensitive and resistant to imatinib to Aurora kinase inhibitor MK-0457 | Mancini M.; Aluigi M.; Leo E.; Marcozzi C.; Castagnetti F.; Barbieri E.; Santucci MA. | 2012-01-01 | BRITISH JOURNAL OF HAEMATOLOGY | - | 1.01 Articolo in rivista | - |
| IG-IMRT VS HDR-BRT in low risk prostate cancer: comparison of techniques. The Sant'Orsola-Malpighi's Hospital experience | Bordonaro L.; Pieri M.; Capuccini J.; Cammelli S.; Galuppi A.; Veraldi a.; Tolento G.; Ntreta M.;... Angelini a.; Romani F.; Bertaccini A.; Barbieri E.; Mazzarotto R. | 2012-01-01 | - | - | 4.03 Poster | - |
| Soft tissue sarcoma treated with postoperative pulsed-dose-rate brachytherapy and external beam radiotherapy | Medoro S.; Galuppi A.; Cammelli S.; Bordonaro L.; Arcelli A.; Ferraro A.; Lombardo E.; BIanchi G....; Barbieri E. | 2012-01-01 | - | - | 4.03 Poster | - |
| The role of brachytherapy in the treatment of vulvar cancer | Cima S.; Arcelli A.; Galuppi A.; S. Cammelli; Enzo L.; Barbieri E. | 2012-01-01 | - | - | 4.03 Poster | - |
| Chemotherapy followed by chemoradiotherapy in locally advanced pancreatic cancer:A literature review and report of two cases |
Di Marco M; Macchini M; Vecchiarelli S; Casadei R; Pezzilli R; Fanti S; Zanoni L; Calculli L; Ba...rbieri E; Santini D; DI Cicilia R; Brandi G; Biasco G. |
2011-01-01 | ONCOLOGY LETTERS | - | 1.01 Articolo in rivista | - |
| Hupofractionated IG-IMRT and acute toxicity in prostate cancer: the experience of the department of radiotherapy Sant'Orsola-Malpighi Hospital, Bologna | M.Mazza; A.Malorgio; F.Bunkheila; S.Cammelli; M.Ntreta; A.Angelini; A.Bertaccini; R.Mazzarotto; E....Barbieri | 2011-01-01 | ANTICANCER RESEARCH | - | 4.02 Riassunto (Abstract) | - |
| Nonmetastatic Ewing family tumors: high-dose chemotherapy with stem cell rescue in poor responder patients. Results of the Italian Sarcoma Grouo/Scandinavian Sarcoma Group III protocol | S. Ferrari; H.K. Sundby; R. Luksch; A. Tienghi; T. QWiebe.F. Fagioli; TA Alvegard; A. Brach Del P...rever; A. Tamburini; M. Alberghini. L. Gendola; M. Mercuri; R. Capanna; S. Mapelli; A. Prete; M. Carli; P. Picci; E. Barbieri; G. Bacci; S. Smeland | 2011-01-01 | ANNALS OF ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Randomised clinical trial: preventive treatment with topical rectal beclomethasone dipropionate reduces post-radiation risk of bleeding in patients irradiated for prostate cancer | Fuccio L; Guido A; Laterza L; Eusebi LH; Busutti L; Bunkheila F; Barbieri E; Bazzoli F. | 2011-01-01 | ALIMENTARY PHARMACOLOGY & THERAPEUTICS | - | 1.01 Articolo in rivista | - |
| Successful radiotherapy for local control of progressively increasing metastasis of gastrointestinal stromal tumor. | Lolli C.; Pantaleo M.A.; Nannini M.; Saponara M.; Pallotti M.C.; Di Scioscio V.; Barbieri E.; Man...drioli A.; Biasco G. | 2011-01-01 | RARE TUMORS | - | 1.01 Articolo in rivista | 3143-22854-2-PB.pdf |
| A new non peptidic inhibitor of the 14-3-3 docking site induces apoptotic cell death in cronic myloid leukemia sensitive or resistant to imatinib. | M. Mancini. V. Corradi; S. Petta; E. Barbieri; F. Manetti; M: Notta; MA Santucci | 2010-01-01 | JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS | - | 1.01 Articolo in rivista | - |
| Image-guided radiotherapy in real time with 3D-conformational radiotherapy with epid system imagin in prostate cancer. | S.CAMMELLI; C.BLASI; L.BORDONARO; F.BUNKHEILA; F.LABROPOULOS; A.MALORGIO; M.MAZZA; M.PIERI; E.BAR...BIERI; R.MAZZAROTTO | 2010-01-01 | TUMORI | - | 4.02 Riassunto (Abstract) | - |
| Lithium induces mortality in medulloblastoma cell lines | Ronchi A; Salaroli R; Rivetti S; Della Bella E; Di Tomaso T; Voltattorni M; Cammelli S; Ceccarell...i C; Giangaspero F; Barbieri E; Cenacchi G. | 2010-01-01 | INTERNATIONAL JOURNAL OF ONCOLOGY | - | 1.01 Articolo in rivista | - |
| mTOR inhibitor RAD001 (Everloimus) enhances the effects of imatinib in chronic myeloid leukemia by raising the nuclear expression of c-Abl protein | M. Mancini; V. Corradi; S. Petta; G. Martinelli; E. Barbieri; M.A. Santucci | 2010-01-01 | LEUKEMIA RESEARCH | - | 1.01 Articolo in rivista | - |
| Neoadjuvant therapy for resectable pancreatic adenocarcinoma: An interim report of a prospective randomized study | M. Di Marco; M. Macchini; R. di Cicilia; S. Vecchiarelli; R. Casadei; E. Barbieri; L. Calculli; M.... A. Pantaleo; G. Biasco | 2010-01-01 | JOURNAL OF CLINICAL ONCOLOGY | - | 4.02 Riassunto (Abstract) | - |
| Prognostic factors in resected pancreatic cancer:a single centre experience | M.Di Marco;M.Macchini|;M.D'ambra;C.Ricci|;S.Vecchiarelli;M.C.Pallotti;;B.Melotti;F.Sperandi;R.Pez...zilli;L.Calculli;D.Santini;E.Barbieri;C.Serra;R. Casadei;F.Minni;A.A.Martoni;G.Biasco | 2010-01-01 | I SUPPLEMENTI DI TUMORI | - | 4.02 Riassunto (Abstract) | - |
| RAD001 (everolimus) prevents mTOR and Akt late re-activation in response to imatinib in chronic myeloid leukemia | M. Mancini; S. Petta; G. Martinelli; E. Barbieri; M.A. Santucci | 2010-01-01 | JOURNAL OF CELLULAR BIOCHEMISTRY | - | 1.01 Articolo in rivista | - |
| Radiotherapy treatment for pediatric central nervous system tumours (CNS) | A.CECCONI; A.GUIDO; L.TONTINI; F.BUNKHEILA; A.PRETE; E.BARBIERI | 2010-01-01 | TUMORI | - | 4.02 Riassunto (Abstract) | - |
| Risk Factors in Resected Pancreatic Cancer. A Single Centre Experience | Macchini M1; Vecchiarelli S; Di Marco M; D’Ambra M; Ricci C; Pallotti MC; Melotti B; Sperandi F; ...Pezzilli R; Calculli L; Santini D; Barbieri E; Serra C; Casadei R; Minni F; Martoni AA; Biasco G | 2010-01-01 | JOP. JOURNAL OF THE PANCREAS | - | 4.02 Riassunto (Abstract) | - |